Zydus Cadila gets DCGI approval for human clinical trials of COVID-19 vaccine
The assent for human trials was given after the company submitted data of clinical trial on animals to the DCGI, in which the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
Mylan gets approval to make and market remdesivir
Jubilant, BDR and Dr Reddy's Labs have also awaiting permission from CDSCO to manufacture and market the drug in India and are…
COVAXIN from Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials
The human trials of this vaccine candidate for COVID-19, indigenously developed in collaboration with ICMR-NIV, will start across…
Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara Reddy
Companies investing in backward integration, new age technology, etc. would get the preference in the PLI scheme
Hetero Healthcare to supply 20,000 vials of Covifor (Remdesivir) across India
Covifor is the first generic brand of Remdesivir which is indicated for the treatment of COVID-19 patients in adults and children,…
Cipla launches remdesivir under brand name CIPREMI
The product will be in the form of lyophilised powder for injection 100 mg
Cipla, Hetero get DCGI nod to manufacture remdesivir
With this move, domestic production of remdesivir for “restricted emergency use” can begin
CDSCO to inspect BDR Pharma’s formulation facility, submit report in seven days
It is part of fast-tracking manufacturing and marketing applications of remdesivir, informs CDSCO
Umifenovir gets DCGI nod for Phase III clinical trial against COVID-19
CSIR-CDRI has developed the process technology for Umifenovir and licensed the process technology for manufacturing and marketing…
Telangana DCA issues approx 110 licenses for manufacturing hand sanitisers
Approves only those based on CDSCO-approved compositions